Resultados: 5

Executive summary of the KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease: Known knowns and known unknowns

Levin, Adeera; Ahmed, Sofia B; Carrero, Juan Jesus; Foster, Bethany; Francis, Anna; Hall, Rasheeda K; Herrington, Will G; Hill, Guy; Inker, Lesley A; Kazancıoğlu, Rümeyza; Lamb, Edmund; Lin, Peter; Madero, Magdalena; McIntyre, Natasha; Morrow, Kelly; Roberts, Glenda; Sabanayagam, Dharshana; Schaeffner, Elke; Shlipak, Michael; Shroff, Rukshana; Tangri, Navdeep; Thanachayanont, Teerawat; Ulasi, Ifeoma; Wong, Germaine; Yang, Chih-Wei; Zhang, Luxia; Robinson, Karen A; Wilson, Lisa; Wilson, Renee F; Kasiske, Bertram L; Cheung, Michael; Earley, Amy; Stevens, Paul E.

Kidney int; 105 (4), 2024

Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) updates the KDIGO 2012 guideline and has been developed with patient partners, clinicians, and researchers around the world, using robust methodology. This update, based on a su...

Insuficiência Renal Crônica/tratamento farmacológico, Insuficiência Renal Crônica/diagnóstico, Taxa de Filtração Glomerular, Creatinina/análise, Albumina Sérica/análise, Controle Glicêmico, Inibidores da Enzima Conversora de Angiotensina/uso terapêutico, Inibidores do Transportador 2 de Sódio-Glicose/uso terapêutico, Anemia/terapia

Texto completo

Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

Rossing, Peter; Caramori, Luiza M; Chan, Juliana C. N; Earley, Amy; de Boer, Ian H.

Kidney int; 102 (5), 2022

The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...

Insuficiência Renal Crônica/tratamento farmacológico, Diabetes Mellitus Tipo 2/prevenção & controle, Autogestão, Controle Glicêmico, Inibidores da Enzima Conversora de Angiotensina/uso terapêutico, Antagonistas de Receptores de Angiotensina/uso terapêutico, Inibidores do Transportador 2 de Sódio-Glicose/uso terapêutico

Texto completo

Guías de práctica clínicas prevención secundaria de la enfermedad renal crónica

Clinical practice guidelines for secondary prevention of chronic kidney disease

Chile. Ministerio de Salud. Gobierno de Chile.

Entregar recomendaciones para apoyar a los equipos de salud en la toma de decisiones respecto al diagnóstico, tratamiento y derivación de las personas con ERC....

Insuficiência Renal Crônica/prevenção & controle, Insuficiência Renal Crônica/diagnóstico, Insuficiência Renal Crônica/tratamento farmacológico, Taxa de Filtração Glomerular, Proteinúria/urina, Albuminúria/urina, Antivirais/uso terapêutico, Antibacterianos/uso terapêutico, Hipolipemiantes/uso terapêutico, Insulina/uso terapêutico

Texto completo

Chronic kidney disease in adults: assessment and management

England. National Institute for Health and Care Excellence.

This guideline covers the care and treatment of people with, or at risk of developing, chronic kidney disease. It aims to prevent or delay the progression of chronic kidney disease, reduce or prevent the development of complications, and reduce the risk of cardiovascular disease....

Insuficiência Renal Crônica/diagnóstico, Insuficiência Renal Crônica/prevenção & controle, Insuficiência Renal Crônica/tratamento farmacológico, Anti-Hipertensivos/uso terapêutico, Sistema Renina-Angiotensina, Inibidores da Agregação Plaquetária/uso terapêutico, Anticoagulantes/uso terapêutico

Texto completo

Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians

Qaseem, A; Hopkins, RH Jr; Sweet, D. E; Starkey, M; Shekelle, P.

Ann. intern. med; 159 (12), 2013

DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...

Insuficiência Renal Crônica/diagnóstico, Insuficiência Renal Crônica/tratamento farmacológico, Progressão da Doença, Triagem, Antagonistas de Receptores de Angiotensina/uso terapêutico, Inibidores da Enzima Conversora de Angiotensina/uso terapêutico, Anti-Hipertensivos/uso terapêutico, Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico, Hipolipemiantes/uso terapêutico, Genfibrozila/uso terapêutico, Doenças Assintomáticas, Quimioterapia Combinada, Abordagem GRADE

Texto completo